New gel shows promise for stubborn back itch
NCT ID NCT06262607
First seen Nov 01, 2025 · Last updated Apr 22, 2026 · Updated 26 times
Summary
This study tested a gel called CLE-400 on 59 adults with Notalgia Paresthetica, a condition that causes long-term itching on the back. The goal was to see if the gel reduces itch intensity better than a placebo gel. Participants applied the gel daily and reported their worst itch each day for 4 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PRURITUS IN ADULT SUBJECTS WITH NOTALGIA PARESTHETICA (NP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site 02
Indianapolis, Indiana, 46250, United States
-
Clinical Site 06
San Antonio, Texas, 78213, United States
-
Clinical Site 09
Dublin, Ohio, 43016, United States
-
Clinical Site 10
North Miami Beach, Florida, 33116, United States
-
Clinical Site 13
Margate, Florida, 33063, United States
-
Clinical Site 15
New York, New York, 10028, United States
-
Clinical Site 20
Portsmouth, New Hampshire, 03801, United States
-
Clinical Site 21
Fremont, California, 94538, United States
-
Clinical Site 23
Methuen, Massachusetts, 01844, United States
-
Clinical site 01
Coral Gables, Florida, 33134, United States
-
Clinical site 03
High Point, North Carolina, 27262, United States
-
Clinical site 11
Bryant, Arkansas, 72022, United States
-
Clinical site 16
Houston, Texas, 77004, United States
Conditions
Explore the condition pages connected to this study.